AXIOMPHARMACEUTICALS
Research Use Only18+Not for Human ConsumptionReconstitution Materials Not Supplied
Comparisons

Cognition research

Selank vs Semax

Two neuropeptide research compounds with different behavioural literature.

Overview

This comparison separates Selank and Semax for laboratory reference—not product selection.

Selank: derivative of Selank with improved stability, blood-brain barrier penetration, and extended half-life compared to parent compound. Parent compound Selank approved in Russia since e…

Semax: and stabilized version of Russian nootropic Semax with stability, extended half-life, and bioavailability through acetylation and amidation modifications.

Differences

  • Selank is commonly discussed in anxiolytic and GABAergic modulation research.
  • Semax is commonly discussed in neurotrophic and cognitive performance models.

Mechanism

Selank: derivative of Selank with improved stability, blood-brain barrier penetration, and extended half-life compared to parent compound. Parent compound Selank approv…

Semax: and stabilized version of Russian nootropic Semax with stability, extended half-life, and bioavailability through acetylation and amidation modifications.

Pharmacology

Selank: derivative of Selank with improved stability, blood-brain barrier penetration, and extended half-life compared to parent compound. Parent compound Selank approv…

Semax: and stabilized version of Russian nootropic Semax with stability, extended half-life, and bioavailability through acetylation and amidation modifications.

Research

Selank: Tissue repair & recovery: derivative of Selank with improved stability, blood-brain barrier penetration, and extended half-life compared to parent compound. Parent compou…

Semax: Cognition & neuromodulation: and stabilized version of Russian nootropic Semax with stability, extended half-life, and bioavailability through acetylation and amidation m…

Summary

DimensionSelankSemax
Mechanismderivative of Selank with improved stability, blood-brain barrier penetration, and extended half-life compared to parent compound. Parent compound Sel…and stabilized version of Russian nootropic Semax with stability, extended half-life, and bioavailability through acetylation and amidation modificati…
Research focusTissue repair & recovery: derivative of Selank with improved stability, blood-brain barrier penetration, and extended half-life compared to parent compound. Parent compou…Cognition & neuromodulation: and stabilized version of Russian nootropic Semax with stability, extended half-life, and bioavailability through acetylation and amidation m…
Pharmacologyderivative of Selank with improved stability, blood-brain barrier penetration, and extended half-life compared to parent compound. Parent compound Selank approv…and stabilized version of Russian nootropic Semax with stability, extended half-life, and bioavailability through acetylation and amidation modifications.
Receptor / targetSee primary literature.and TrkB

Distinction

  • AXIOM does not provide dosing, administration, or protocol guidance.
  • Catalogue links appear only where AXIOM lists a research-use product.
  • Reference-only compounds remain comparison terms without implying availability.

References

Questions

Does this page recommend Selank or Semax?

No. It is an editorial comparison for research context only.

Does AXIOM provide protocol guidance?

No. Protocol and dosing decisions belong with qualified laboratory teams and source literature.

Available from AXIOM

Catalogue

Labelled strengths and batch records where available.